Repligen Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance

Go back to Repligen Reports First Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance

Repligen (RGEN) Tops Q1 EPS by 5c, Lowers FY23 Guidance

May 2, 2023 7:34 AM EDT

Repligen (NASDAQ: RGEN) reported Q1 EPS of $0.64, $0.05 better than the analyst estimate of $0.59. Revenue for the quarter came in at $182.7 million versus the consensus estimate of $182.19 million.

GUIDANCE:

Repligen sees FY2023 EPS of $2.35-$2.42, versus the consensus of $2.64. Repligen sees... More